Posted in | News | Imaging

Leica Microsystems Gains Access to Olympus’ Digital Pathology Patents

Leica Microsystems and Olympus America have entered into a non-exclusive licensing agreement. As per the worldwide licensing deal, Leica will gain access to Olympus’ range of patents in the field of virtual microscopy and digital pathology.

The patents include equipment and methods for delivering, storing and creating virtual microscopy slides. The technology allows users to observe and share virtual microscopy images of high-resolution over the Internet.

The Group VP and General Manager of the Scientific Equipment Group at Olympus America, Osamu Joji believes that as the digital slide scanning market is on the rise, it is important to gain access to the patents held by Olympus. Access to these technologies will also help in bringing advancements to the field of pathology and in turn ensure better healthcare for patients across the globe.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Leica Microsystems GmbH. (2023, April 14). Leica Microsystems Gains Access to Olympus’ Digital Pathology Patents. AZoOptics. Retrieved on November 23, 2024 from https://www.azooptics.com/News.aspx?newsID=13573.

  • MLA

    Leica Microsystems GmbH. "Leica Microsystems Gains Access to Olympus’ Digital Pathology Patents". AZoOptics. 23 November 2024. <https://www.azooptics.com/News.aspx?newsID=13573>.

  • Chicago

    Leica Microsystems GmbH. "Leica Microsystems Gains Access to Olympus’ Digital Pathology Patents". AZoOptics. https://www.azooptics.com/News.aspx?newsID=13573. (accessed November 23, 2024).

  • Harvard

    Leica Microsystems GmbH. 2023. Leica Microsystems Gains Access to Olympus’ Digital Pathology Patents. AZoOptics, viewed 23 November 2024, https://www.azooptics.com/News.aspx?newsID=13573.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.